Yasuhide Hori

发表

Manserin as a novel histochemical neuroendocrine marker in prostate cancer.

Tomomi Yamada, Y. Iwamoto, Y. Sugimura, 2013, Urologic oncology.

Heterogenous induction of carcinoma‐associated fibroblast‐like differentiation in normal human prostatic fibroblasts by co‐culturing with prostate cancer cells

K. Iguchi, T. Tsunoda, A. Mizokami, 2011, Journal of cellular biochemistry.

Naftopidil, a Selective α1-Adrenoceptor Antagonist, Suppresses Human Prostate Tumor Growth by Altering Interactions between Tumor Cells and Stroma

Y. Iwamoto, Y. Sugimura, K. Ishii, 2011, Cancer Prevention Research.

The long-term results with delayed-combined androgen blockade therapy in local or locally advanced prostate cancer.

Y. Sugimura, Yuji Ogura, N. Hayashi, 2012, Japanese journal of clinical oncology.

Structural changes in α1-adrenoceptor antagonist-treated human prostatic stroma

Y. Sugimura, K. Ishii, Tetsuya Imamura, 2010, Clinical and Experimental Medicine.

Plasma sFas and sFas ligand levels in patients with thrombotic thrombocytopenic purpura and in those with disseminated intravascular coagulation

H. Shiku, H. Wada, K. Nishii, 1999, American journal of hematology.

Effect of transforming growth factor α overexpression on urogenital organ development in mouse.

Y. Sugimura, K. Ishii, Norihito Soga, 2010, Differentiation; research in biological diversity.

Limited expression of cancer-testis antigens in renal cell carcinoma patients.

K. Yamakado, H. Ikeda, H. Shiku, 2013, Molecular and clinical oncology.

Photoselective vaporization of the prostate using high power (80 W) KTP laser: One year follow up of the first 101 patients in Japan

Y. Sugimura, Yasuhide Hori, I. Kuromatsu, 2008, International journal of urology : official journal of the Japanese Urological Association.

Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure

H. Matsuura, Yasuhide Hori, S. Arase, 2018, International Journal of Clinical Oncology.

First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors

H. Ikeda, E. Sato, H. Shiku, 2020, Cancer Immunology, Immunotherapy.

Radiofrequency Ablation Combined with Renal Arterial Embolization for the Treatment of Unresectable Renal Cell Carcinoma Larger Than 3.5 cm: Initial Experience

K. Takeda, H. Takaki, K. Yamakado, 2006, CardioVascular and Interventional Radiology.

Ureteral obstruction associated with pelvic inflammatory disease in a long‐term intrauterine contraceptive device user

Y. Sugimura, N. Toyoda, K. Arima, 2006, International journal of urology : official journal of the Japanese Urological Association.

[A case of primary malignant lymphoma of the prostate with characteristic MRI findings].

Y. Sugimura, H. Kanda, K. Arima, 2013, Hinyokika kiyo. Acta urologica Japonica.

Clinical outcomes and prognostic factors associated with internal ureteral stent placement for malignant extrinsic ureteral obstruction

H. Matsuura, Yasuhide Hori, S. Arase, 2020, Supportive Care in Cancer.